Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    PTC Therapeutics Inc.

    NASDAQ: PTCT · Real-Time Price · USD
    49.77
    0.95 (1.95%)
    At close: Aug 18, 2025, 3:59 PM
    49.00
    -1.55%
    Pre-market: Aug 19, 2025, 06:59 AM EDT

    PTC Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -363.3M -626.6M -559.02M -523.9M
    Depreciation & Amortization
    		 75.66M 236.59M 128.84M 64.13M
    Stock-Based Compensation
    		 74.61M 131.21M 110.33M 103.51M
    Other Working Capital
    		 121.25M 5.72M -57.74M -4.01M
    Other Non-Cash Items
    		 58.7M 151.32M 82.81M 128.33M
    Deferred Income Tax
    		 -55.91M -46.93M -34.28M 377K
    Change in Working Capital
    		 102.54M -4M -85.33M -23.79M
    Operating Cash Flow
    		 -107.69M -158.42M -356.65M -251.33M
    Capital Expenditures
    		 -6.5M -120.62M -152.46M -85.33M
    Cash Acquisitions
    		 n/a n/a 128.44M 57.12M
    Purchase of Investments
    		 -669.93M -212.48M -75.55M -543.27M
    Sales Maturities Of Investments
    		 597.74M 156.37M 518.19M 847.78M
    Other Investing Acitivies
    		 122.88M -92.18M -128.44M -57.12M
    Investing Cash Flow
    		 44.18M -176.74M 290.18M 219.18M
    Debt Repayment
    		 -1.49M -301.38M 148.72M -2.22M
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 223.59M 917.78M -30.77M n/a
    Financial Cash Flow
    		 255.87M 646.4M 167.95M 20.88M
    Net Cash Flow
    		 185.03M 314.36M 98.71M -19.09M
    Free Cash Flow
    		 -114.19M -279.04M -509.11M -336.66M

    Add to Watchlist